Previous Article | Next Article ![]()
Infection and Immunity, March 2001, p. 1256-1264, Vol. 69, No. 3
Department of Microbiology, University of
Minnesota Medical School, Minneapolis, Minnesota 55455
Received 30 May 2000/Returned for modification 11 August
2000/Accepted 20 November 2000
The superantigenic function of toxic shock syndrome toxin 1 (TSST-1) is generally regarded as an important determinant of its
lethal effects in humans or experimental animals. This study examined
the role of superantigenicity in a BALB/c mouse model of lethal
TSST-1-induced hypersensitivity to lipopolysaccharide (LPS). In this
model, TSST-1 greatly potentiated both LPS-induced lethality, as well
as LPS-induced serum tumor necrosis factor alpha (TNF-
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1256-1264.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Role of T Cells and Gamma Interferon during
Induction of Hypersensitivity to Lipopolysaccharide by Toxic Shock
Syndrome Toxin 1 in Mice
) activity.
Although BALB/c-SCID mice were resistant to these LPS enhancement
effects of TSST-1, BALB/c-SCID mice reconstituted with T cells were
completely susceptible to the enhancement effect of TSST-1 on
LPS-induced serum TNF-
. Mice pretreated with cyclosporine (Cs) or
neutralizing antibodies against gamma interferon (IFN-
) did not
develop lethal LPS hypersensitivity when injected with TSST-1, and
these agents reduced the enhancement effect of TSST-1 on LPS-induced
serum TNF-
by 99 and 85%, respectively. Cs pretreatment also
completely inhibited the known capacity of TSST-1 to amplify LPS-induced levels of IFN-
in serum. In contrast, mice given Cs
after a priming injection of TSST-1, but before LPS, still exhibited
lethal hypersensitivity to LPS. Cs given after TSST-1 also did not
inhibit enhancement of LPS-induced serum TNF-
by TSST-1 but
inhibited the enhancement effect of TSST-1 on LPS-induced serum IFN-
by 50%. These experiments support the theory that TSST-1-induced
hypersensitivity to LPS is mediated primarily by IFN-
derived from
superantigen-activated T cells.
*
Corresponding author. Mailing address: Department of
Microbiology, University of Minnesota Medical School, 420 Delaware St., SE, Minneapolis, MN 55455. Phone: (612) 624-9471. Fax: (612) 626-0623. E-mail: pats{at}lenti.med.umn.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»